Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies

A D Meringa; P Hernández-López; A Cleven; M de Witte; T Straetemans; J Kuball; D X Beringer; Z Sebestyen

doi:10.3389/fimmu.2023.1159337

Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies

A D Meringa, P Hernández-López, A Cleven, M de Witte, T Straetemans, J Kuball, D X Beringer, Z Sebestyen

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Article number	1159337
Pages (from-to)	1-7
Journal	Frontiers in Immunology
Volume	14
DOIs	https://doi.org/10.3389/fimmu.2023.1159337
Publication status	Published - 2023

Keywords

antigen
cancer
fitness
immune therapy
migration
T-cell therapy
TME (tumor microenvironment)
γδTCR

Access to Document

10.3389/fimmu.2023.1159337Licence: CC BY

fimmu-14-1159337Final published version, 734 KBLicence: CC BY

Cite this

@article{7fb99ac9f6ae44938cde5ebd9bf7956f,

title = "Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies",

keywords = "antigen, cancer, fitness, immune therapy, migration, T-cell therapy, TME (tumor microenvironment), γδTCR",

author = "Meringa, {A D} and P Hern{\'a}ndez-L{\'o}pez and A Cleven and {de Witte}, M and T Straetemans and J Kuball and Beringer, {D X} and Z Sebestyen",

note = "Funding Information: This work was supported by Grants KWF 11979, KWF 11393, KWF 12586, KWF 13043, KWF 13493 to authors JK, ZS and DB from the Dutch Cancer Society KWF. ",

year = "2023",

doi = "10.3389/fimmu.2023.1159337",

language = "English",

volume = "14",

pages = "1--7",

journal = "Frontiers in Immunology",

issn = "1664-3224",

publisher = "Frontiers Media S. A.",

}

TY - JOUR

T1 - Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies

AU - Meringa, A D

AU - Hernández-López, P

AU - Cleven, A

AU - de Witte, M

AU - Straetemans, T

AU - Kuball, J

AU - Beringer, D X

AU - Sebestyen, Z

N1 - Funding Information: This work was supported by Grants KWF 11979, KWF 11393, KWF 12586, KWF 13043, KWF 13493 to authors JK, ZS and DB from the Dutch Cancer Society KWF.

PY - 2023

Y1 - 2023

KW - antigen

KW - cancer

KW - fitness

KW - immune therapy

KW - migration

KW - T-cell therapy

KW - TME (tumor microenvironment)

KW - γδTCR

UR - http://www.scopus.com/inward/record.url?scp=85164818137&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2023.1159337

DO - 10.3389/fimmu.2023.1159337

M3 - Comment/Letter to the editor

C2 - 37441064

SN - 1664-3224

VL - 14

SP - 1

EP - 7

JO - Frontiers in Immunology

JF - Frontiers in Immunology

M1 - 1159337

ER -

Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies

Keywords

Access to Document

Other files and links

Cite this